Iterum Therapeutics plc (ITRMF) Other Non-Current Liabilities (2017 - 2024)

Iterum Therapeutics' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $16000.0 for Q2 2024.

• In Q2 2024, Other Non-Current Liabilities fell 98.6% year-over-year to $16000.0; the TTM figure through Jun 2024 stood at $16000.0 (down 98.6% YoY), while the FY2023 annual figure was $188000.0, down 85.58% from the prior year.
• Other Non-Current Liabilities for Q2 2024 stood at $16000.0, down from $92000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $7.2 million in Q3 2020, with the low at $16000.0 in Q2 2024.
• The 5-year median for Other Non-Current Liabilities is $2.5 million (2022), against an average of $3.0 million.
• The sharpest annual moves came in 2020 and 2024: Other Non-Current Liabilities dropped 2.73% in 2020, then plunged 98.6% in 2024.
• Iterum Therapeutics' Other Non-Current Liabilities stood at $5.8 million in 2020, then plunged by 40.78% to $3.4 million in 2021, then sank by 62.05% to $1.3 million in 2022, then tumbled by 85.58% to $188000.0 in 2023, then tumbled by 91.49% to $16000.0 in 2024.
• Business Quant data shows ITRMF's Other Non-Current Liabilities at $16000.0 in Q2 2024, $92000.0 in Q1 2024, and $188000.0 in Q4 2023.